Protocol of a Nationwide Observational Study among Patients with Nontuberculous Mycobacterium Pulmonary Disease in South Korea (NTM-KOREA)

Tuberculosis and Respiratory Diseases

article

Nakwon Kwak¹  Hongjo Choi²  Doosoo Jeon³  Byung Woo Jhun⁴  Kyung-Wook Jo⁵  Young Ae Kang⁶  Yong-Soo Kwon⁷  Myungsun Lee⁸  Jeongha Mok⁹  Tae-Sun Shim⁵  Hong-Joon Shin⁷  Jake Whang²  Jae-Joon Yim¹ 

[1] Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine;Research Center, Korean Institute of Tuberculosis;Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital;Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine;Division of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine;Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine;Department of Internal Medicine, Chonnam National University Hospital;Clinical Research Section, International Tuberculosis Research Center;Division of Pulmonology, Department of Internal Medicine, Pusan National University Hospital

关键词: Nontuberculous Mycobacteria;    Protocol;    Registry;   

DOI  :  10.4046/trd.2019.0077

学科分类：医学（综合）

来源: The Korean Academy of Tuberculosis and Respiratory Diseases

【 摘 要 】

Background The burden of nontuberculous mycobacterial (NTM) pulmonary disease (PD) is increasing globally. To understand the treatment outcomes and prognosis of NTM-PD, a unified registry is needed. In this project, we aim to construct a multicenter prospective observational cohort with NTM-PD in South Korea (NTM-KOREA). Methods The primary objective of this study is to analyze treatment outcomes according to the species. In addition, recurrence rate, adverse events, the impact of each drug on treatment outcomes as well as the impact of characteristics of mycobacteriology will be analyzed. The inclusion criteria for the study are as follows: fulfilling the criteria for NTM-PD having one of the following etiologic organisms: Mycobacterium avium complex, M. abscessus subspecies abscessus , M. abscessus subspecies massiliense , or M. kansasii ; receiving the first treatment for NTM-PD after enrollment; age >20 years; and consenting to participate in the study. Seven institutions will participate in patient enrollment and about 500 patients are expected to be enrolled. Participants will be recruited from 1 March 2020 until 19 March 2024 and will be observed through 19 March 2029. During the follow-up period, participants' clinical course will be tracked and their clinical data as well as NTM isolates will be collected. Conclusion NTM-KOREA will be the first nationwide observational cohort for NTM-PD in South Korea. It will provide the information to optimize treatment modalities and will contribute to deeper understanding of the treatment outcomes and long-term prognosis of patients with NTM-PD in South Korea.

【 授权许可】

CC BY-NC